TP53 and neoplasm: Instead clonal selection, driven by the loss of canonical p53 function or the dominant-negative effect that reduced the tumor suppressor activity of wild-type p53, was suggested as the most prominent factor in the selective advantage associated with p53 mutations (25, 26).